Kisho is an information platform, not a medical provider. Nothing on this site constitutes medical advice, diagnosis, or treatment recommendations. All content is aggregated from publicly available sources (including ClinicalTrials.gov, PubMed, FDA.gov, and Orphanet) and is provided for informational purposes only. Clinical trial eligibility, treatment decisions, and any health-related actions should always be discussed with a qualified healthcare professional. Kisho does not endorse any specific therapy, organization, or clinical trial. Terms of use · Privacy policy
A primary, low grade carcinoma of the thyroid gland composed of groups of squamoid and mucous cells, surrounded by fibrous tissue. Prominent cystic structures may be present. The clinical course is usually indolent.
Biomarker and diagnostic research for thyroid gland mucoepidermoid carcinoma has been reported in the published literature.
No clinical trials have been registered for thyroid gland mucoepidermoid carcinoma.
14 publications have been identified in PubMed for thyroid gland mucoepidermoid carcinoma. Research spans Case Report / Case Series (50%), Diagnostic / Biomarker (14%), and Review / Meta-Analysis (14%).
Research Type | Count | % of Total |
|---|---|---|
Patient case studies | 7 | 50% |
Data assembled from 2 of 12 sources · Last updated Sep 19, 2026, 6:57 PM UTC
Testing and diagnosis research
2 |
14% |
Research summaries | 2 | 14% |
Other research | 1 | 7% |
Laboratory research | 1 | 7% |
Disease patterns and progression | 1 | 7% |
Kundi FCS (2026). [PMID: 41505004](https://pubmed.ncbi.nlm.nih.gov/41505004/). *Head Neck Pathol*. [Diagnostic / Biomarker]
Dixit S (2026). [PMID: 41545802](https://pubmed.ncbi.nlm.nih.gov/41545802/). *Virchows Arch*. [Basic Science / Preclinical]
Allen DZ (2026). [PMID: 41834435](https://pubmed.ncbi.nlm.nih.gov/41834435/). *Head Neck*. [Diagnostic / Biomarker]
Farhadi A (2026). [PMID: 41994062](https://pubmed.ncbi.nlm.nih.gov/41994062/). *J Dent (Shiraz)*. [Epidemiology / Natural History]
Şiraz ÜG (2026). [PMID: 40099975](https://pubmed.ncbi.nlm.nih.gov/40099975/). *J Clin Res Pediatr Endocrinol*. [Case Report / Case Series]
Han Q (2025). [PMID: 40022195](https://pubmed.ncbi.nlm.nih.gov/40022195/). *J Med Case Rep*. [Review / Meta-Analysis]
Zhang C (2025). [PMID: 40612341](https://pubmed.ncbi.nlm.nih.gov/40612341/). *Front Oncol*. [Case Report / Case Series]
Torres W (2025). [PMID: 41647838](https://pubmed.ncbi.nlm.nih.gov/41647838/). *Front Oncol*. [Case Report / Case Series]
Othman BK (2025). [PMID: 39537991](https://pubmed.ncbi.nlm.nih.gov/39537991/). *Virchows Arch*. [Case Report / Case Series]
Akhvlediani G (2024). [PMID: 39618593](https://pubmed.ncbi.nlm.nih.gov/39618593/). *Cureus*. [Case Report / Case Series]
AI-curated news mentioning thyroid gland mucoepidermoid carcinoma
Updated Aug 29, 2026
A study identifies a PRKACA gene duplication at 19p13.12 in a female patient with primary pigmented nodular adrenal disease (PPNAD) and thyroid carcinoma, highlighting a potential genetic link after a 20-year diagnostic journey. This discovery may inform future research and treatment strategies for these conditions.
A recent international multicenter study provides insights into the prognostic stratification of brain metastases from nonanaplastic follicular cell-derived thyroid carcinoma. The findings may enhance understanding of disease progression and treatment strategies.
A recent study published in PubMed highlights the clinicopathologic and molecular characteristics of poorly differentiated thyroid carcinomas in adults aged 45 and younger. This research may provide insights into the unique features of this aggressive cancer subtype.